ciprofloxacin has been researched along with leflunomide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Cheam, H; Ettenger, RB; Malekzadeh, MH; Tsai, EW; Zaman, RA | 1 |
| Habib, S; Latiolais, LS; McClure, GB; Reisman, L; Vanchiere, JA | 1 |
| Al-Otaibi, T; Gheith, O; Halim, MA; Mosaad, A; Nair, P; Nampoory, N; Said, T; Zkaria, Z | 1 |
| Burger-Calderon, R; Jeffers-Francis, LK; Webster-Cyriaque, J | 1 |
| Botelho-Nevers, E; Gagneux-Brunon, A; Laurent, B; Lucht, F; Mariat, C; Michalet, M; Pillet, S | 1 |
1 review(s) available for ciprofloxacin and leflunomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for ciprofloxacin and leflunomide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
A novel treatment regimen for BK viremia.
Topics: Adolescent; BK Virus; Child; Ciprofloxacin; Female; Fluoroquinolones; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Nucleic Acid Synthesis Inhibitors; Polyomavirus Infections; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Tumor Virus Infections; Viremia | 2014 |
Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child.
Topics: Administration, Oral; Biopsy; BK Virus; Child, Preschool; Ciprofloxacin; Creatinine; Cytosine; DNA, Viral; Female; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Renal Insufficiency; Renal Insufficiency, Chronic; Viral Load | 2014 |
Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Middle Aged; Polyomavirus Infections; Prospective Studies; Time Factors; Treatment Outcome; Tumor Virus Infections | 2014 |
Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.
Topics: Animals; Antigens, Viral, Tumor; Antiviral Agents; BK Virus; Cells, Cultured; Cidofovir; Ciprofloxacin; Cytosine; Humans; Isoxazoles; Leflunomide; Organophosphonates; RNA, Messenger; RNA, Viral; Salivary Glands; Time Factors; Viral Load; Virus Replication | 2015 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Myelodysplastic Syndromes; Plasmapheresis; Polyomavirus Infections; Renal Insufficiency, Chronic; Tumor Virus Infections; Viral Load; Viremia; Virus Activation | 2015 |